Methotrexat Accord

Methotrexate, the active ingredient in Methotrexat Accord, is an antimetabolite presented as a sterile injectable solution for intraarterial, intramuscular, and intravenous use. It is employed in the management of certain cancers, autoimmune disorders, and trophoblastic diseases in adult and pediatric patients. GNH USA supplies Methotrexat Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexate is an antimetabolite used across several disease families, primarily oncology and autoimmune disorders. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin lesions and plaque formation. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation. - Osteosarcoma: impedes tumor growth and metastasis. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Adverse reactions may range from mild to life‑threatening and should be monitored throughout therapy.

Common Side Effects: - Nausea and vomiting - Fatigue or malaise - Mucositis or oral ulceration - Alopecia (hair loss) - Elevated liver enzymes - Skin rash or pruritus

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia - Severe hepatotoxicity or hepatic fibrosis - Pulmonary toxicity, including interstitial pneumonitis - Renal impairment or acute kidney injury - Life‑threatening infections - Anaphylactic or severe hypersensitivity reactions

Methotrexate requires careful monitoring and specific safety measures before and during treatment. - Blood count monitoring: perform complete blood counts regularly to detect myelosuppression. - Liver function assessment: check hepatic enzymes before initiation and periodically thereafter. - Renal function evaluation: assess creatinine clearance to adjust dosing in renal impairment. - Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception for both sexes. - Drug interaction review: avoid concomitant use with known contraindicated agents. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexate interacts with several drug classes, necessitating vigilance to prevent toxicity or reduced efficacy.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate plasma levels and risk of toxicity. - Trimethoprim‑sulfamethoxazole: synergistic myelosuppression. - Live vaccines: heightened risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine or other immunosuppressants: additive bone‑marrow suppression. - Phenytoin: may alter methotrexate metabolism. - Folic acid supplementation: can reduce efficacy; dose adjustments may be required.